Evidence map›Paper›PMID 30207979›Full record

ArticleCanadian family physician Medecin de famille canadien2015

Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians.

Pamela Leece, Aaron Orkin, Rita Shahin, Leah S Steele

Open access · greenAbstract read
In one paragraph

Article in Canadian family physician Medecin de famille canadien, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  3. Review
  4. Article
  5. Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pamela LeeceResident in the Public Health and Preventive Medicine Program at the Dalla Lana School of Public Health at the University of Toronto in Ontario. pamela.leece@mail.utoronto.ca.
Aaron OrkinClinical Public Health Fellow at the Dalla Lana School of Public Health at the University of Toronto.
Rita ShahinAssociate Medical Officer of Health at Toronto Public Health and Adjunct Professor at the Dalla Lana School of Public Health.
Leah S SteeleAssistant Professor in the Department of Family and Community Medicine at the University of Toronto and Associate Scientist in the Li Ka Shing Knowledge Institute of St Michael's Hospital in Toronto.
Public Health Ontario · CASt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore family physicians' attitudes toward prescribing naloxone to at-risk opioid users, as well as to determine the opportunities and challenges for expanding naloxone access to patients in family practice settings.

designOne-hour focus group session and SWOT (strengths, weaknesses, opportunities, and threats) analysis.

settingWorkshop held at the 2012 Family Medicine Forum in Toronto, Ont.

participantsSeventeen conference attendees from 3 Canadian cities who practised in various family practice settings and who agreed to participate in the workshop.

methodsThe workshop included an overview of information about naloxone distribution and overdose education programs, followed by group discussion in smaller focus groups. Participants were instructed to focus their discussion on the question, "Could this [overdose education and naloxone prescription] work in your practice?" and to record notes using a standardized discussion guide based on a SWOT analysis. Two investigators reviewed the forms, extracting themes using an open coding process. MAIN

findingsSome participants believed that naloxone could be used safely among family practice patients, that the intervention fit well with their clinical practice settings, and that its use in family practice could enhance engagement with at-risk individuals and create an opportunity to educate patients, providers, and the public about overdose. Participants also indicated that the current guidelines and support systems for prescribing or administering naloxone were inadequate, that medicolegal uncertainties existed for those who prescribed or administered naloxone, and that high-quality evidence about the intervention's effectiveness in family practice was lacking.

conclusionFamily physicians believe that overdose education and naloxone prescription might provide patients at risk of opioid overdose in their practices with broad access to a potentially lifesaving intervention. However, they explain that there are key barriers currently limiting widespread implementation of naloxone use in family practice settings.

Identifiers

PMID30207979
PMCPMC4463897
OpenAlexW2260392056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.